AIM
DGX icon

Acropolis Investment Management’s Quest Diagnostics DGX Stock Holding History

Acropolis Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$481K Sell
2,268
-208
-8% -$40.8K 0.02% 191
2026
Q1 		$485K Sell
2,476
-117
-5% -$22.7K 0.02% 183
2025
Q4 		$450K Sell
2,593
-863
-25% -$157K 0.02% 184
2025
Q3 		$621K Sell
3,456
-8
-0.2% -$1.42K 0.03% 152
2025
Q2 		$622K Buy
3,464
+4
+0.1% +$695 0.03% 136
2025
Q1 		$585K Sell
3,460
-155
-4% -$25.5K 0.03% 135
2024
Q4 		$545K Sell
3,615
-489
-12% -$76.1K 0.03% 148
2024
Q3 		$637K Sell
4,104
-350
-8% -$52.3K 0.04% 128
2024
Q2 		$610K Sell
4,454
-247
-5% -$33.8K 0.04% 132
2024
Q1 		$626K Sell
4,701
-675
-13% -$87.6K 0.04% 131
2023
Q4 		$740K Sell
5,376
-1,041
-16% -$137K 0.05% 111
2023
Q3 		$782K Sell
6,417
-3,232
-33% -$431K 0.06% 104
2023
Q2 		$1.36M Sell
9,649
-198
-2% -$27.3K 0.11% 76
2023
Q1 		$1.39M Buy
9,847
+262
+3% +$37.5K 0.11% 76
2022
Q4 		$1.5M Buy
9,585
+179
+2% +$25.7K 0.13% 63
2022
Q3 		$1.15M Sell
9,406
-105
-1% -$13.8K 0.12% 72
2022
Q2 		$1.26M Buy
9,511
+143
+2% +$19.5K 0.12% 69
2022
Q1 		$1.28M Buy
9,368
+214
+2% +$29.8K 0.12% 78
2021
Q4 		$1.58M Buy
9,154
+1,213
+15% +$185K 0.14% 60
2021
Q3 		$1.15M Buy
7,941
+322
+4% +$47.1K 0.14% 73
2021
Q2 		$1M Buy
7,619
+332
+5% +$43.5K 0.1% 81
2021
Q1 		$935K Buy
7,287
+577
+9% +$71.1K 0.1% 81
2020
Q4 		$800K Buy
6,710
+462
+7% +$56.3K 0.09% 85
2020
Q3 		$715K Buy
6,248
+200
+3% +$23.6K 0.09% 85
2020
Q2 		$689K Buy
6,048
+1,165
+24% +$124K 0.09% 85
2020
Q1 		$392K Buy
4,883
+213
+5% +$22.1K 0.06% 104
2019
Q4 		$499K Sell
4,670
-30
-0.6% -$3.13K 0.07% 105
2019
Q3 		$503K Buy
4,700
+100
+2% +$10.3K 0.07% 98
2019
Q2 		$468K Buy
4,600
+120
+3% +$11.5K 0.07% 92
2019
Q1 		$403K Sell
4,480
-50
-1% -$4.33K 0.06% 97
2018
Q4 		$377K Buy
4,530
+305
+7% +$28.6K 0.07% 96
2018
Q3 		$456K Buy
4,225
+680
+19% +$74.6K 0.07% 90
2018
Q2 		$390K Sell
3,545
-4,815
-58% -$502K 0.06% 92
2018
Q1 		$839K Buy
8,360
+2,455
+42% +$251K 0.14% 75
2017
Q4 		$582K Sell
5,905
-80
-1% -$7.58K 0.09% 82
2017
Q3 		$560K Sell
5,985
-2,690
-31% -$286K 0.09% 78
2017
Q2 		$964K Buy
8,675
+650
+8% +$68.7K 0.16% 66
2017
Q1 		$788K Buy
8,025
+275
+4% +$26.2K 0.14% 72
2016
Q4 		$712K Buy
7,750
+1,570
+25% +$135K 0.13% 75
2016
Q3 		$523K Buy
6,180
+325
+6% +$27.3K 0.1% 85
2016
Q2 		$477K Buy
5,855
+95
+2% +$7.23K 0.09% 88
2016
Q1 		$412K Buy
5,760
+4,155
+259% +$279K 0.08% 93
2015
Q4 		$114K Buy
+1,605
New +$108K 0.02% 125

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Acropolis Investment Management's DGX Position: Q2 2026 in Review

Acropolis Investment Management reduced its Quest Diagnostics (DGX) stake by 8.4% in Q2 2026, selling an estimated $40.8K and leaving 2,268 shares worth $481K. The position accounts for 0.02% of the portfolio, ranked #191.

Acropolis Investment Management first reported a position in DGX in Q4 2015 and has held it in 43 quarters since. The position peaked at $1.58M in Q4 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Acropolis Investment Management held 2,268 shares of Quest Diagnostics worth $481K as of Q2 2026.
  • Acropolis Investment Management sold 208 Quest Diagnostics shares in Q2 2026, an estimated $40.8K.
  • Quest Diagnostics made up 0.02% of Acropolis Investment Management's portfolio in Q2 2026, its #191 holding.
  • Acropolis Investment Management first reported a position in Quest Diagnostics in Q4 2015 and has held it in 43 quarters since.
  • Acropolis Investment Management's Quest Diagnostics position peaked at $1.58M in Q4 2021.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Acropolis Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.